Efficacy of in vitro sensitized cells generated by in vivo priming with OK-432 for adoptive immunotherapy of the poorly immunogenic B 16-BL6 melanoma
Authors:
- 29 February 1996
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 18 (2) , 141-153
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Generation of T-Cells Reactive to the Poorly Immunogenic B16-BL6 Melanoma with Efficacy in the Treatment of Spontaneous MetastasesJournal of Immunotherapy, 1993
- A novel role for autologous tumour cell vaccination in the immunotherapy of the poorly immunogenic B16-BL6 melanomaSurgical Oncology, 1992
- Production of inteleukin 6 by human spleen cells stimulated with streptococcal preparation OK-432Immunology Letters, 1989
- Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancerCancer, 1987
- Spontaneous regional lymph node metastases of three variants of the B16 melanoma: Relationship to primary tumor size and pulmonary metastasJournal of Surgical Oncology, 1986
- Interferon‐γ Induction in Human Peripheral Blood Mononuclear Cells by OK‐432, a Killed Preparation of Streptococcus pyogenesMicrobiology and Immunology, 1986
- Augmentation of interleukin 1 and interleukin 2 production by OK-432International Journal of Immunopharmacology, 1985
- Neutrophil-Mediated Tumor Cell Destruction in Cancer AscitesCancer, 1982
- Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.Journal of Experimental Medicine, 1980
- A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous originBritish Journal of Cancer, 1976